The Zhitong Finance App learned that Everbright Securities released a research report saying that taking into account factors such as the impact of collection, the company's cost reduction, and focus on core business, minimally invasive healthcare (00853.HK) is expected to achieve continuous loss reduction. The net profit forecast for 25-26 years was raised to -30/96 million US dollars (the original value was -59/91 million US dollars), and the net profit forecast for 27 years was 133 million US dollars. The company is a leading domestic high-value consumables enterprise. It has strong R&D capabilities and maintains a “buy” rating.

The Zhitong Finance App learned that Everbright Securities released a research report saying that taking into account factors such as the impact of collection, the company's cost reduction, and focus on core business, minimally invasive healthcare (00853.HK) is expected to achieve continuous loss reduction. The net profit forecast for 25-26 years was raised to -30/96 million US dollars (the original value was -59/91 million US dollars), and the net profit forecast for 27 years was 133 million US dollars. The company is a leading domestic high-value consumables enterprise. It has strong R&D capabilities and maintains a “buy” rating.